Quantitative analysis of nerve growth factor in the amniotic fluid during chick embryonic development  by Mashayekhi, Farhad et al.
Saudi Journal of Biological Sciences (2011) 18, 209–212King Saud University
Saudi Journal of Biological Sciences
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEQuantitative analysis of nerve growth factor in the
amniotic ﬂuid during chick embryonic developmentFarhad Mashayekhi a,*, Elham Dianati b, Lotfali Masomi Moghadam ba Department of Biology, Faculty of Sciences, University of Guilan, Namjo Street, Rasht 1914, Iran
b Department of Biology, Faculty of Sciences, University of Mohagegh Ardabili, Ardabil, IranReceived 1 May 2010; revised 4 July 2010; accepted 18 July 2010
Available online 21 July 2010*
66
E
13
El
Pe
doKEYWORDS
Amniotic ﬂuid;
Chick;
Concentration;
ELISA;
Nerve growth factor;
Western blottingCorresponding author. Te
90447.
-mail address: umistbiology
19-562X ª 2011 King Saud
sevier B.V. All rights reserve
er review under responsibilit
i:10.1016/j.sjbs.2010.07.001
Production and hl.: +98
@yahoo.
Universit
d.
y of King
osting by EAbstract Nerve growth factor (NGF) and most neurotrophic factors support the proliferation and
survival of particular types of neurons. Besidesthe pivotal role of NGF in the development of neu-
ronal cells, it also has important functions on non-neuronal cells. The amnion surrounds the
embryo, providing an aqueous environment for the embryo. A wide range of proteins has been
identiﬁed in human amniotic ﬂuid (AF). In this study, total protein concentration (TPC) and
NGF level in AF samples from chick embryos were measured using a Bio-Rad protein assay,
enzyme linked immunosorbent assay (ELISA) and Western blot. TPC increased from days E10
to day E18. There was a rapid increase in AF TPC on day E15 when compared to day E16. No
signiﬁcant changes in NGF levels have been seen from day E10 to day E14. There was a rapid
increase in NGF content on days E15 and E16, and thereafter the levels decreased from day E16
to day E18. Since, NGF is important in brain development and changes in AF NGF levels have
been seen in some CNS malformations, changes in the TPC and NGF levels in AF during chick
embryonic development may be correlated with cerebral cortical development. It is also concluded
that NGF is a constant component of the AF during chick embryogenesis.
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lsevier1. Introduction
Nerve growth factor (NGF), originally identiﬁed as a neurite-
promoting factor in peripheral sensory and sympathetic neu-
rons, has been shown to function in the central nervous system
(Spranger et al., 1990; Chiaretti et al., 2008). NGF, discovered
almost half a century ago, is the founding and best-character-
ized member of neurotrophin family (Levi-Montalcini, 1987;
Chao, 1992). The biological function of NGF is the mainte-
nance and survival of the nervous system. Besides the pivotal
role of NGF in the development of neuronal cells, it also has
important functions on non-neuronal cells. For example, it is
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cia et al., 1996).
The neurotrophins represent a family of structurally and
functionally related, homodimeric proteins, including NGF,
brain derived neurotrophic factor (BDNF), neurotrophin-3
(NT-3), NT-4, NT-4/5 andNT-6 (Go¨tz et al., 1994). NGF exerts
its differentiating and proliferation effects on the CNS during
embryonic development. Some non-neuronal cell types can re-
lease NGF in a paracrine/autocrine fashion (Jiang et al., 1997).
Biological actions of NGF are mediated by two distinct
receptors, the high-afﬁnity trkANGFR receptor and the low-
afﬁnity p75NTR receptor (Yano and Chao, 2000). It has been
shown that NGF exerts indirect pro-angio-genetic effects medi-
ated by speciﬁc angiogenic factors in the developing CNS (Calza
et al., 2001) and that it induces increased expression of inﬂam-
matory markers in skin vessels (Raychaudhuri et al., 2001).
The amnion,which is the innermembrane, surrounds the em-
bryo, forming the amniotic cavity, providing an aqueous envi-
ronment for the embryo. The amnion contains a ﬂuid to
protect the embryo from infection,mechanical injury, and adhe-
sion. The chick begins imbibing the amniotic ﬂuid (AF) around
day 13 of incubation and continues until day 19 of incubation.
Hence, the embryo is exposed to and swallows the ﬂuid contain-
ing proteins, minerals, water, hormones and any other nutrients
needed for growth and development (Karcher et al., 2005).
AF is crucial to fetal health because it forms a protective sac
around the infant that prevents mechanical and thermal shock,
possesses antimicrobial activity, assists in acid/base balance, and
contains nutritional factors. A wide range of proteins has been
identiﬁed in human AF (Burdett et al., 1982). In human, these
proteins can enter the amniotic ﬂuid from the maternal uterine
tissues, umbilical cord, amniotic ﬂuid cells, fetal urine, meco-
nium, and other fetal secretions that include transudation
through fetal skin (Jauniaux et al., 1998). There is also a dynamic
temporal pattern, with AF total protein concentrations rising
from 7 to 20 weeks gestation (Benzie et al., 1974).
In this study, the total protein concentration (TPC) in chick
amniotic ﬂuid was determined by the Bio-Rad protein assay
based on the Bradford dye-binding procedure. The presence
and level of NGF in chick amniotic ﬂuid was measured by en-
zyme linked immunosorbent assay (ELISA) and Western blot.
2. Material and methods
2.1. Amniotic ﬂuid samples
Fertile white Leghorn eggs were incubated at 38 C in a
humidiﬁed atmosphere to obtain chick embryos at different
stages of development. The amniotic ﬂuid was carefully aspi-
rated using a pulled tip glass microcapillary pipette (Drum-
mond Scientiﬁc Company, 20 lL) from incubated chick
embryos from day 10 to day 18 (E10–E18).
Amniotic ﬂuid for each analysis was collected from 28 chick
embryos. The amount of 0.5 ml amniotic ﬂuid was collected
from each embryo. To minimize protein degradation, amniotic
ﬂuid samples were kept at 4 Cduring collection. Amniotic ﬂuid
samples were centrifuged at 15,000 rpm at 4 C for 10 min to re-
move any contaminating cells. The samples that we used for
analysis had no visible sign of contaminating red blood cells that
we could detect under the microscope. The supernatant was fro-
zen immediately and stored at 70 C until future analysis.Twenty eight samples from each time point were used for anal-
ysis of total protein and NGF concentration.
2.2. Total protein and NGF analysis
The total protein concentration of proteins in the amniotic
ﬂuid was determined by the Bio-Rad protein assay based on
the Bradford dye procedure. NGF in amniotic ﬂuid was mea-
sured using the sensitive two-site ELISA and antiserum against
chick NGF. Microtiter plates (Dynatech, Canada) were ﬁrst
coated with 80 ng primary anti-NGF antibody (Abcam) per
well in 0.1 M Tris buffer. After overnight incubation, the
plates were blocked with EIA buffer (50 mM Tris pH 7.5,
0.3 M NaCl, 0.1% Triton X-100, 1% BSA and 1% gelatin).
The samples and standards were placed in triplicate wells
and incubated overnight at room temperature. After washing
with phosphate buffered saline (PBS) a biotinylated secondary
antibody (8 ng/mL) was added to each well and incubation
was carried out overnight at room temperature. b-Galactosi-
dase coupled to avidin was then added for 2 h followed by
washing. Finally, 200 lM 4-methylumbelliferyl-b-galactoside
(Sigma–Aldrich, Poole, UK) in 50 mM sodium phosphate
were added as well as 10 mM MgCl2 buffer and the amount
of ﬂuorescence was measured after 50 min incubation at
37 C using a ﬂuorimeter (Dynatech, Canada).
For Western Blot analysis, aliquots of amniotic ﬂuid from
the embryos were mixed with a sample buffer containing
3.2% SDS, 15% glycerol, 2.8 M b-mercaptoeyhanol and
0.0015% bromophenol blue. Samples were applied to a 5–
20% gradient SDS–PAGE gel (Bio-Rad) according to Lamely
and the proteins obtained were transferred to nitrocellulose
sheets, pore size 0.45 lm (Bio-Rad). After incubation for 2 h
at room temperature in the blocking solution (PBS containing
5% skimmed milk), the nitrocellulose sheets were exposed
overnight, at 4 C, to anti-NGF monoclonal antibody and
identiﬁed with a peroxidase-labeled mouse IgM PK 4010 Vec-
tastain Avidin Biotin complex kit (Vectorlab.). The peroxidase
activity was revealed with diaminobenzidine (0.5 mg/ml in PBS
with 0.02% hydrogen peroxide).
All animal procedures were carried out in accordance with
the Animals Act, 1986. All values were expressed as
mean ± standard error of the mean (SEM). In all experiments,
a minimum of 28 measurements were made in order to calcu-
late a mean ± SEM. Statistical analysis was performed using
Student’s t test and only values with P 6 0.05 were considered
statistically signiﬁcant.
3. Results
3.1. Total protein concentration
The total protein concentration in AF in embryos aged E10–
E18 was determined by Bio-Rad protein assay. The total pro-
tein concentration increased from day E10 to day E18. There
was a rapid increase in AF TPC on day E16 when compared
to day E15 (Fig. 1).
3.2. NGF concentration
The presence of NGF in the AF samples was shown using
Western blot (Figs. 2 and 3). Using ELISA, we have also
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Figure 1 Total protein concentration in the amniotic ﬂuid
samples from days E10 to E18 (g/l). Signiﬁcant increase in AF
total protein concentration has been seen in E16 when compared
with E15 (P< 0.001). ***P< 0.001 (n= 28 at each time point).
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Figure 3 Signal intensities from the anti-NGF-1 immunoblot-
ting experiments were determined by densitometric analysis.
Results shown are mean ± standard error of the mean. Signiﬁcant
increase in AF NGF level has been seen in E15 when compared
with E14 (P< 0.001). ***P< 0.001 (n= 28 at each time point).
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Figure 4 Nerve growth factor concentration in the cerebrospinal
ﬂuid samples from days E10 to E21 (pg/ml). Signiﬁcant increase in
AF NGF level has been seen in E15 when compared with E14
(P< 0.001). ***P< 0.001 (n= 28 at each time point).
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chick embryos aged E10–E18. No signiﬁcant changes in
NGF levels have been seen from days E10 to day E14. There
was a peak in NGF concentration on days E15 and E16, after
that NGF levels decreased from days E16 to day E18 (Fig. 4).
The mean NGF concentration in the AF from day 14 was
0.40 ± 0.03 ng/ml, which was signiﬁcantly higher than the
0.43 ± 0.03 ng/ml of the AF from day 15 (P< 0.001).
4. Discussion
We have previously shown that NGF is an important growth
factor in cerebral cortical development by stimulating neuronal
precursor cell proliferation (Mashayekhi and Salehi, 2007).
Using anti-NGF antibody we have demonstrated that NGF
has an important role in neuronal cell death in the developing
cerebral cortex (Mashayekhi, 2008. It has also been demon-
strated that NGF induces eukaryotic translation initiation fac-
tor 4E (eIF4E) in brain tissue (Salehi and Mashayekhi, 2007).
To our knowledge, this is the ﬁrst study to investigate the
concentrations of NGF in the chick amniotic ﬂuid. We inves-
tigated NGF as it is the ﬁrst discovered and one of the most
important neurotrophins (Shooter, 2001). Neurotrophins are
important for the development and maintenance of the ner-
vous system. NGF, the best characterized member of the neu-
rotrophin family, sends its survival signals through activation
of TrkA. NGF promotes survival events even at low concen-
trations of NGF if TrkA is co-expressed on the cell surface
(Yano and Chao, 2000).
AF is important to fetal health because it forms a protective
sac around the embryo that contains nutritional and growth
factors (Stewart et al., 2001). A wide range of proteins has
been identiﬁed in human AF. In humans, there are dynamic
temporal patterns with AF total protein concentrations risingFigure 2 Western blot analysis of NGF expression in the AF
from days E10 to E18. b-Tubulin (50-kDa) expression was
determined as a protein loading control (n= 28 at each time
point).from 7 to 20 weeks of gestation (Tisi et al., 2004). Fetal swal-
lowing represents the principle mechanism of clearance of AF
protein, which is thought to have a half-life of 1–2 days in
monkeys; however, before keratinization of fetal skin at 24
weeks, diffusion of the lower-molecular weight proteins across
unkeratinized fetal skin may occur (Dale et al., 1985). Fetal
swallowing of AF begins early in development (Ross and
Brace, 2001), where it is shown that proteins can be absorbed
from AF by the developing fetuses of rats and monkeys (Lev
and Orlic, 1972).
In this study we have shown that total protein concentra-
tion in AF increases from days E10 to day E18. We have also
shown that there is no signiﬁcant change in NGF levels in AF
from days E10 to day E14. There was a peak in AF NGF levels
on days E15 and E16, after that NGF levels decrease from
days E16 to E18.
5. Conclusions
Since NGF is important in brain development and changes in
AF NGF levels has been seen in some CNS malformations,
changes in the total protein concentration and NGF levels dur-
ing chick embryonic development may be correlated with cere-
bral cortical development. It is also concluded that NGF is a
constant component of the AF during chick embryogenesis.
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